Debiopharm deployed Genialis Expressions in its own cloud to standardize omics analysis for biomarker discovery.

Debiopharm relied on different vendors and workflows to process omics data, making datasets hard to compare. It deployed Genialis Expressions in its cloud infrastructure for biomarker discovery and multiomics analytics. The page reports a centralized in-house platform with standardized, model-ready outputs and cross-study comparability, without figures.

Genialis is an AI biomarker company offering the Supermodel and ResponderID to predict patient response in oncology drug development.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.